Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CHRS

Coherus Oncology, Inc.

CIK 0001512762 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.63
↓ 0.02 (-1.21%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options

Key stats

Market Cap
$251.43M
P/E Ratio
1.35
EPS
1.43
Dividend Yield
Not covered
52W Position
46%
Beta
2.12

Valuation multiples

Fwd P/E
41.15
PEG
0.00
P/B
3.20
P/S
5.36
EV/Revenue
2.90
ROE
236.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 46%
$0.80$2.62

Latest Financials

2025-12-31 FY
Revenue
$42.17M
Net Income
$168.02M
Total Assets
$258.34M
Free Cash Flow
–

Recent news